CHINA MEDICAL SYSTEM HLDGS LTD
(HKEX: 867)

China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.

13.370 -

-0.360 (-2.62%)
Range 12.960 - 13.910   (7.33%)
Open 13.730
Previous Close 13.730
Bid Price 13.360
Bid Volume ('000) 27
Ask Price 13.370
Ask Volume ('000) 54
Volume ('000) 7,934.1
Value 104,718,704
Remark -
Delayed prices. Updated at 24 Apr 2026 16:08.
Data powered by

Upcoming Events

Dividend

Ex-Date 27 April 2026
Record Date 27 April 2026
Payable Date 27 April 2026
DIVIDEND : HKD 0.155
View All Events


Loading Chart...

Please login to view stock data and analysis